Who is eligible for clinical trial NCT06982235?

Participants must meet protocol criteria for Benign Prostate Hypertrophy(BPH). Confirm exact inclusion and exclusion requirements with the study coordinator.

Does clinical trial NCT06982235 provide travel or cost reimbursement?

Check with the site coordinator at the participating facility for travel and lodging stipend availability, and for which routine-care costs are covered.

🏛️ Verified NIH Record • Updated 2026-08-10

Stone and Laser Therapies Post-Market Study (SALT) (NCT06982235)

🔵 Active, Not Recruiting Interventional Protocol 📊 Observational Clinical Research Sponsor: Boston Scientific Corporation

🩺 Plain-English Summary (8th-Grade Level)

The objective of the SALT Study is to obtain post-market safety and device performance data for Boston Scientific's Stone and BPH study devices used during a diagnostic and/or therapeutic urinary tract procedure (e.g., transurethral or percutaneous access routes) or benign prostatic hyperplasia (BPH) treatment.

Who can join: To join this study, participants generally need to meet the listed inclusion criteria (7 items) and avoid the listed exclusions (6 items).

Location: Mayo Clinic Phoenix — Phoenix, Arizona

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Check every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).

For urinary tract procedure cohort:
Subject intends to undergo diagnostic and/or therapeutic urinary tract procedure with qualified BSC device(s)
Subject is willing and able to complete all follow-up visits For BPH cohort:
Subject is ≥ 40 years of age
Subject with a diagnosis of benign prostatic hyperplasia (BPH) with lower urinary tract symptoms
Subject intends to undergo BPH treatment with qualified BSC device(s)
Subject is willing and able to complete all follow-up visits

Usually NOT eligible if any of the following apply:

Exclusion Criteria: For urinary tract procedure cohort:
Subject requires simultaneous surgical treatment for BPH
Unwilling or unable to provide consent
Any other condition which, in the opinion of the investigator, precludes study participation (e.g., history of medical non-compliance, etc.) For BPH cohort:
Unwilling or unable to provide consent
Any other condition which, in the opinion of the investigator, precludes study participation (e.g., history of medical non-compliance, etc.)

🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.

📍 All Participating Trial Locations (5 Sites)

Mayo Clinic Phoenix — Phoenix, Arizona
University of Miami Hospital — Miami, Florida
University of South Florida — Tampa, Florida
Indiana University Medical Center — Indianapolis, Indiana
Duke University Medical Center — Durham, North Carolina

💰 Cost, Insurance & Patient Rights

100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

🏛️ View Official NIH Record ↗